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Effect of anion exchange inhibitors and para-aminohippurate on the
transport of urate in the rat proximal tubule. The present studies were
designed to examine the effect of some anion exchange inhibitors and
para-aminohippurate (PAH) on urate transport in the proximal tubule of
the rat utilizing microperfusion techniques. The addition of SITS,
DIDS, or furosemide to the luminal perfusion solution resulted in a
decreased rate of absorption of water and 2-14C-urate. In addition, the
presence of PAH in the luminal microperfusion solution resulted in a
lower rate of urate absorption. The absorptive flux of urate was
significantly higher, however, when PAH was added to the solution
microperfusing the capillaries. The capillary to lumen secretory flux of
orate was significantly higher when PAH or unlabeled urate was added
to the luminal perfusion solution and significantly lower when PAH was
added to the capillary perfusion solution. The addition of SITS to either
the capillary or luminal microperfusion solution resulted in lower
secretory and absorptive fluxes of urate. These studies suggest that
both the secretion and reabsorption of orate in the proximal convoluted
tubule of the rat is influenced by some anion exchange inhibitors and
PAH. The results are considered in conjunction with recent in vitro data
suggesting that orate transport is mediated by a process of anion
exchange.
Effet des inhibiteurs de l'echange anionique et du para-aminohippurate
sur Ic transport de l'urate dans le tubule proximal de rat. Cette étude a
été concue afin d'examiner l'effet de certains inhibiteurs de l'échange
anionique et du para-aminohippurate (PAH) sur Ic transport d'urate
dans Ic tubule proximal de rat en utilisant des techniques de microperfu-
sion. L'addition de SITS, de DIDS ou de furosémide a La solution de
perfusion luminale a entrainé une diminution du taux d'absorption
d'eau et de 2-'4C-urate. En outre Ia presence de PAH dans Ia solution
de microperfusion luminale a entrainé un pius faible taux d'absorption
de l'urate. Le flux d'absorption de l'urate était toutefois significative-
ment plus élevC lorsque Ic PAH Ctait ajoutC a Ia solution perfusant les
capillaires. Les flux sCcrétoires du capillaire vers Ia lumière de l'urate
étaient significativement plus éleves lorsque le FAH ou de l'urate
nonmarque étaient ajoutCs a Ia solution de perfusion luminale, et
significativement plus faibles lorsque le PAH était ajouté a Ia solution
de perfusion capillaire. L'addition de SITS aux solutions de microperfu-
sions capillaire ou luminale a entrainC des flux de secretion ct d'absorp-
tion d'urate plus faibles. Ces etudes suggèrent que Ia sécrCtion et Ia
reabsorption d'urate dans Ic tubule contourné proximal de rat sont
influencées par certains inhibiteurs d'echanges anioniques et Ic PAH.
Ces résultats sont CtudiCs en fonction des donnCes rCcentes obtenues in
vitro suggerant que le transport de l'urate est médié par un processus
d'echange anionique.
Free-flow micropuncture studies in the rat have indicated
that there is net reabsorption of urate by the end of the proximal
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convoluted tubule [1—51. In at least some of the above free-flow
micropuncture studies and in a prior simultaneous capillary and
luminal microperfusion study, the concentration ratio of urate
in the collected luminal fluid to that in the peritubular capillary
circulation was significantly less than one [3, 5, 6]. Given a
reasonable estimate of the luminal potential difference at these
late proximal tubule sites, these data would indicate that the
tubular reabsorption of urate represents an active transport
process. Other in vivo studies have indicated that the absorp-
tion of urate was not intimately linked to that of sodium and
that, in contrast to glucose, some amino acids and phosphate,
urate and sodium do not share a co-transport system [7—131.
The driving force for the tubular absorption of urate has been
examined recently in isolated brushborder membranes. Blom-
stedt and Aronson [141, Kahn and Aronson [15, 16], and
Guggino, Martin, and Aronson [17] have presented a series of
experiments in the dog indicating that the transport of orate and
para-aminohippurate (PAH) in the brushborder membrane rep-
resents a process of anion exchange. In the presence of a
hydroxyl ion or other specific anion gradient, the uptake of
orate and PAH could be demonstrated to transiently overshoot
their equilibrium concentrations. Similar findings have been
found in a brushborder preparation of the rat as reported from
our laboratories [181.
It also seems clearly established that the proximal convoluted
tubule of the rat is capable of urate secretion. Precession
studies as well as simultaneous capillary and luminal microper-
fusion studies have indicated that the secretory process was a
mediated transport system [19—221. Some question remains,
however, as to whether or not any or all portions of the
proximal tubule are capable of uphill or active secretion of urate
[2, 3, 23]. In a recent study utilizing isolated basolateral
membrane vesicles from the rat, Abramson et a! [24] presented
evidence that the uptake of urate is a mediated transport
mechanism that is inhibitable by pyrazinoate and oxanate.
Recent and preliminary data from our laboratories indicate that
the uptake of urate across basolateral membrane vesicles of the
rat is saturable, inhibitable by probenecid and DIDS, and
capable of exchange diffusion [25].
The effect of anion exchange inhibitors on the transport of
urate in the mammalian kidney, studied in vivo, has not been
examined previously. In addition, the effect of PAH on the
transport of urate has received only limited study [19, 26—281.
Accordingly, the present studies in the rat were designed to
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examine the effects of SITS, DIDS, furosemide, and PAH on
the transport of urate in the proximal convoluted tubule.
Methods
Male Sprague-Dawley rats with access to food and water
prior to the study were anesthetized with pentobarbital (50
mg/kg body weight i.p.) and prepared for micropuncture as
previously described [22]. Surgical losses of fluid were replaced
with a volume of isotonic saline equal to 1% of body weight.
Isotonic saline was infused intravenously throughout the ex-
periment at a rate of 1.2 mI/hr. In any given animal, two to four
microperfusion samples were obtained.
Luminal microperfusion studies. Segments of the proximal
convoluted tubules were microperfused between oil blocks at a
flow rate of 17.5 nI/mm using methods previously described [6].
The perfusion solution contained 150 m sodium, 129 mM
chloride, 25 m bicarbonate, and 4 m potassium (7.4 pH, 288
mOsm/kg H20). Inulin [3H Methoxy] (New England Nuclear
Corp., Boston, Massachusetts) and [2-14C] urate (Amersham!
Searle Corp., Arlington Heights, Illinois) were added to the
luminal perfusion solution. The concentration of urate was
varied over a range from 0.08 to 0.7 mM. Where examined,
SITS (4-acetamido-4'-isothiocyanostilbene-2, 2'-disulfonic
acid) (ltr5 M), DIDS (4-4'-diisothiocyano-2, 2'-disulfonic stil-
bene) (l0— M) or furosemide (10—s M) were added to the
microperfusion solution. After each collection, the lumen was
filled with latex, and the length of the perfused segment was
determined by microdissection.
Simultaneous capillary and luminal microperfusion studies.
The peritubular capillaries were microperfused at a rate of 3
.t1 min with a solution (7.4 pH, 288 mOsm/kg H20) contain-
ing 150 m sodium, 129 m chloride, 25 m bicarbonate, 4 mM
potassium and, in most of the experiments, 0.25 m calcium. In
some studies, the concentration of calcium was increased to 2.5
m. No differences in the fluxes of urate were found over this
range of capillary concentrations of calcium. In the area of the
capillary branch, the lumens of the proximal tubule were
microperfused between oil blocks with a steady state solution
(pH 7.4, 288 mOsm/kg H20) containing 125 mi sodium, 104
m chloride, 25 m bicarbonate, 4 ifiM potassium, and 50 mM
mannitol. Urate [2-'4C] was added to either the luminal or
capillary microperfusion solutions. The concentration of urate
in the capillary and luminal perfusion solutions was 0.4 mM.
The specific activity of urate in the capillary solution was 53
CiIsmo1e and in the luminal solutions it was 10.6 sCi/mole.
Inulin [3H methoxyl was added to the luminal perfusion solu-
tion as a volume marker. Where examined, unlabeled urate,
PAH, or SITS was added to either capillary or luminal perfu-
sion solution in the concentrations indicated in the Results
section. In the studies of urate absorption, the luminal perfusion
rate was 17.5 nl min. In the studies of urate secretion, the
luminal perfusion rate was 25 nl min. Following each
microperfusion, the tubule lumen was filled with latex and the
distance between the perfusion and collection micropipettes
was determined subsequently by microdissection.
Analytic methods and calculations. The radioactivity of the
perfusion and collected solutions was determined in Biofluor
(New England Nuclear Corp.) in a Tri-Carb liquid scintillation
counter (Packard Instruments Co., Downers Grove, Illinois). In
studies where [2-'4C] urate was initially present in the luminal
perfusion solution only, the absorptive flux of urate (Ja) was
calculated from the formula:
Ia = (1 — [(CF/PF)/(CF/PF)1j x Ci x perfusion rate x
length
where CF and PF are the disintegrations per minute of the
collected (CF) and perfusion fluid (PF) of inulin (In) and urate
(U), respectively; Ci is the concentration of urate in the initial
perfusion solution; and length is the distance between the
perfusion and collection sites in millimeters. In the studies
where [2-'4C] urate was initially present in the capillary solution
only, the secretory flux (Js) was calculated from the formula:
(dpm)cJs = x collected volume x length(sp act)
where (dpm)c is the disintegrations per minute per nanoliter of
[2-'4C] urate in the collected luminal perfusate; sp act is the
specific activity of urate in the capillary perfusion solution; and
collected volume is the collected luminal perfusate in nanoliters
per minute. In the luminal microperfusion studies, water ab-
sorption (Jv) was calculated from the expression:
Jv = (I — [PF/CFJ1) x perfusion rate x length'.
The results are expressed as the mean SEM. Statistical
significance was determined by the t test for unpaired data.
Results
Luminal microperfusion studies. Water absorption average
2.31 0.04 nl min' mm in the control studies. The
addition of SITS, DIDS, or Lasix resulted in significantly lower
rates (P <0.05) of water absorption of 1.66 0.09, 1.33 0.03,
and 0.81 0.03 nI . min' mm', respectively. As shown in
Figure 1 and Table 1, there was a relationship between the
absorption of urate and the arithmetic mean intraluminal con-
centration of urate in the control studies. The passive perme-
ability coefficient was determined from the difference in the flux
of urate divided by the difference in the mean intraluminal
concentration of urate from the microperfusion solutions initial-
ly containing urate in concentrations of 0.4 and 0.7 m. The
passive permeability coefficient, calculated in this manner, was
0.8 pmole min mm' Under the conditions of
study, the absorption of urate represents a combined process of
facilitated (active) and passive transport [29]. Since solvent
drag has little, if any, effect on the transport of urate, the
facilitated (active) component of urate transport was deter-
mined by subtracting the flux estimated to be due to passive
permeation from the total flux [29]. The relationship between
the facilitated (active) component of urate transport and the
mean intraluminal concentration of urate is summarized in
Figure lB. Visual inspection of this relationship yields an
estimated Km of 0.14 m and Vmax of 0.25 pmole min'
mm'. The addition of SITS, DIDS, or Lasix in the concentra-
tions indicated, resulted in a lower rate of total urate absorption
as compared to control. The apparent permeability of urate in
the presence of these agents closely approximated the passive
permeability coefficient of urate determined in the control
studies. In the presence of either of these three drugs, the
calculated facilitated component of urate absorption was virtu-
ally zero.
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Fig. 1. The relationship between the total flux of urate (A) and the
calculated facilitated (active) component of urate absorption (B), and
the mean intraluminal concentration of urate utilizing the control
perfusion solution (0), and the perfusion solutions containing SITS
(1OM) (•), DIDS (105M) (A) and furosemide (1O3M) (s). Points
represent the mean values from Table 1.
Simultaneous capillary and luminal microperfusion studies.
When radioactive urate was present in the capillary perfusion
solution, the secretory flux of urate averaged 2.72 0.29 pmole
min' mm' (Table 2). The addition of unlabeled urate (0.4
mM) to the luminal perfusion solution resulted in a significantly
higher flux of [2-'4C1 urate of 3.99 0.56 pmole min mm'
(P < 0.04). To examine the effect of another anion, PAH in
concentrations of 0.41 or 1.23 m was added to the luminal
perfusion solution. Both concentrations resulted in significantly
higher secretory fluxes of urate, but a difference between the
two concentrations of PAH could not be discerned. For all
studies where PAH was present in the lumen, the secretory flux
of urate averaged 3.93 0.41 pmole min mm (P < 0.02).
The addition of PAH (1.23 mM) to the capillary perfusion
solution resulted in a significantly lower secretory flux of urate
of 1.71 0.20 pmole min mm' (P < 0.02).
The absorptive flux of urate averaged 0.65 0.12 pmole
min' mm' (Table 3). The addition of PAH (1.23 mM) to the
capillary perfusion solution resulted in a higher absorptive flux
of urate of 1.17 0.15 pmole min' mm' (P <0.01). As
compared to controls, the addition of PAH (1.23 mM) to the
luminal perfusion solution resulted in a significantly lower flux
of urate of 0.30 0.04 pmole min mm (P <0.02).
In separate studies, the effects of SITS on the absorptive and
secretory fluxes of urate were examined. In each subset of data,
concentrations of SITS of 5 x l0- and 5 x l0- M were
examined. There were no differences between these two con-
centrations and the data were, therefore, combined. As com-
pared to the controls, the secretory flux of urate was significant-
ly lower when SITS was added to either the capillary perfusion
solution (1.57 0.20 pmole min' mm'; P < 0.01) or to the
luminal perfusion solution (1.86 0.20 pmole min' mm; P
< 0.02). The absorptive flux of urate was also significantly
lower, as compared to controls, when SITS was added to the
luminal perfusion solution (0.33 0.08 pmole min mm; P
<0.04) or to the capillary perfusion solution (0.35 0.07 pmole
min1 mm'; P < 0.04).
Discussion
The estimates for the Km, Vmax, and passive permeability
coefficient as determined from the relationship between the
intraluminal concentrations of urate and the absorptive flux of
urate agree well with our prior studies 1291. The addition of
SITS, DIDS, or furosemide to the luminal perfusion solution
significantly inhibited the absorption of water; the findings
agreed with those of Lucci and Warnock [301. We are unaware
of prior in vivo studies in the mammalian kidney examining the
effect of these three anion exchange inhibitors on the transport
of urate by the cells of the renal tubule. In the concentrations
examined, all three agents significantly inhibited the absorption
of urate. The remaining flux of urate in the presence of the
drugs approximated that estimated to occur by passive diffusion
alone. Similar findings with respect to SITS were found in the
simultaneous capillary and luminal microperfusion studies. In
addition, the presence of SITS in the luminal perfusion solution
significantly inhibited the capillary to lumen flux of urate. In
prior preliminary studies utilizing isolated brushborder mem-
brane vesicles from the dog and the rat, both SITS and DIDS
were found to inhibit the anion gradient stimulated uptake of
urate [16, 181. The present in vivo experiments would support
these findings and are consistent with the suggestion that the
transport of urate in the proximal tubule is mediated, at least in
part, by an anion exchange mechanism, Such a conclusion,
however, assumes that these drugs are acting exclusively or
predominantly as anion exchange inhibitors. The side of the cell
on which these agents are acting cannot be determined defini-
tively from the present studies. The fate of these drugs, when
present initially only in the lumen, is unknown and results must
be interpreted with caution. Evidence from other tissue sys-
tems, however, suggest that SITS and DIDS have only a limited
ability to penetrate the cell [311. If such is the case, the present
result suggests that the transport of urate across the brush-
border membrane of the proximal tubule is inhibitable by SITS,
DIDS, and furosemide and is occurring by a process of anion
exchange. While we believe the above to be the most likely
explanation for the effects of SITS, DIDS, and furosemide
when present in the luminal perfusion solution, it is recognized
that similar findings could occur if the drugs in the lumen could
gain access to the basolateral side of the cell. Preliminary
findings from our laboratory indicate that the transport of urate
0.8 A
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Table 1. Absorption of urate in the rat proximal tubule
Urate concentration, mM
0.08 0.2 0.4 0.7
ontrol
N 9 11 9 8
L 1.3 1.2 ±0.1 1.7
e 0.08 0.004 0.21 0.01 0.37 0.02 0.70 0.03
iTotal 0.13 0.01 0.33 0.03 0.55 0.05 0.82 0.05
JActive 0.07 0.01 0.16 0.02 0.25 0.03 0.26 0.02
Jv 2.4 0.4 2.2 0.3 2.3 0.3 2.3 0.4
SITS, iO M
N 6 7 5 10
L 1.1 0.1 1.1 0.1 1.3 0.3 1.0 0.1
e 0.088 0.001 0.19 0.003 0.44 0.02 0.76 0.03
iTotal 0.06 0.01 0.17 0.02 0.35 0.05 0.61 0.07
JActive 0.0l 0.01 0.01 0.02 0.00 0.04 0.00 0.03
Jv 1.7 0.2 1.4 0.1 1.8 0.2 1.7 0.3
DIDS, io M
N 7 6 8 8
L 1.4 0.1 1.0 0.! 1.8 0.2 1.7 0.2
0.08 0.002 0.23 0.03 0.40 0.01 0.77 0.01
jTotat 0.08 0.02 0.21 0.03 0.38 0.04 0.66 0.02
JActive 0.01 0.02 0.04 0.2 0.06 0.04 0.06 0.03
iv 1.4 0.2 1.3 0.2 1.3 0.2 1.3 0.3
Furosemide iO
N 7 8 10 5
L 1.1 ±0.1 1.3 1.1
e 0.08 0.001 0.20 0.003 0.40 0.01 0.69 0.01
JTotaI 0.07 0.01 0.16 0.02 0.37 0.02 0.59 0.04
JActive 0.01 0.02 0.00 0.01 0.05 0.03 0.04 0.02
Jv 0.8 0.1 0.9 0.! 0.8 0.1 0.8 0.4
Abbreviations:
N, the number of tubules; L, length of perfused tubule in mm; ë, the arithmetic mean intraluminal concentration of urate in mM; JTotal, the total
urate flux in pmole min' mm; JActve, the facilitated component of urate absorption in pmole min mm I; iv, the absorption of water in
n1 min mm*
Values represent the mean SEM. Values for JTOtaI and JActive in the experimental groups are significantly lower than control values at all initial
concentrations of urate (P < 0.05).
across basolateral membrane vesicles from the rat kidney
occurs by a saturable process which is inhibitable by DIDS [25].
Moreover, in the present experiments, the addition of SITS to
the capillary perfusion solution inhibited both the absorptive
and secretory fluxes of urate. Thus, it can only be concluded at
this time that SITS, DIDS, and furosemide significantly effect
the transport of urate in the proximal tubule of the rat, but that
additional studies examining the tubular transport of these
drugs and their specificity for the various urate transport
mechanisms in the renal cells will be required to fully interpret
the results.
The results of these studies also indicate a significant effect of
PAR on the transport of urate. The addition of PAR to the
luminal perfusion solution inhibited the absorptive flux of urate
but, in separate studies, enhanced the capillary to lumen
secretory flux. The addition of PAR to the capillary perfusion
solution enhanced the absorptive flux of urate but inhibited the
secretory flux. The findings that PAH both inhibited and
stimulated the transport of urate when present initially on only
one side of the cell makes it unlikely that PAH was exerting its
effects on the transport of urate by altering the passive perme-
ability properties of the cell. The results of these studies should
be considered in conjunction with certain prior studies by other
investigators. Kramp, Lassiter, and Gottshalk [26] suggested
from the results of intraluminal microinjection studies that PAH
inhibits the absorption of urate in the proximal tubule of the rat.
Our results confirm these findings. Boudry [27] reported that
the infusion of PAR decreased the fractional excretion of urate
when the plasma concentration of urate was increased. These
results were interpreted to indicate that PAH inhibited the
tubular secretion of urate. The effects of PAH on the fractional
excretion of urate were less evident at more physiologic con-
centrations of urate. Although he used the renal artery to vein
transit time technique as an estimate of peritubular membrane
uptake of urate, Foulkes [28] was unable to demonstrate an
effect of PAR. Kramp and Lenoir [191 microinjected radioac-
tive urate into the peritubular capillaries and noted that the
urinary recoveries of urate were not influenced by the presence
of PAH. The findings of these latter two studies were interpret-
ed to indicate that urate and PAR do not share a common
transport pathway at the basolateral border of the renal tubular
cells. The results of the present studies are at least consistent
with the conclusion of Boudry but are at variance with those of
Kramp, Lassiter, and Gottshalk [26], Boudry [27], and Foulkes
[28]. Although no definitive explanation of this discrepancy is
available, in both of the latter two studies, urate and PAH were
distributed to multiple nephron segments. If urate and PAR
share a mechanism in some nephron segments but not at others,
the relationship between the concentration of the two anions in
the peritubular capillary blood may be altered during their
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movement down the capillary bed. By contrast, we used shorter
and more defined nephron segments. The rates of perfusion
were such that the concentrations of urate and PAH, particular-
ly in the capillary solutions, were unlikely to change
significantly.
The mechanism of the interaction of PAH with urate is not
elucidated definitively by our studies. Although the net absorp-
tive flux of PAH is small, Baines, Gottschalk, and Lassiter [321
previously reported that following intraluminal microinjection
of PAH, the volume of distribution of PAH exceeded that of
inulin suggesting some reabsorption of PAH with subsequent
return to the urinary stream [32]. In more recent studies in
which brushborder membrane vesicles from both the dog and
the rat were used, it was demonstrated that urate and PAH are
both transported by an anion exchange mechanism and that
urate and PAH mutually trans-stimulate and cis-inhibit the
transport of each other ([14] and Kahn and Aronson, Kahn and
Weinman; unpublished observations). By contrast, in basolat-
eral membrane vesicles of the rat, preliminary data from our
laboratories suggest that while urate and PAH are both trans-
ported by mediated transport mechanisms, there is little or no
effect of PAH on the transport of urate or of urate on the
transport of PAH across this membrane [25]. Based on the in
vitro data just cited, we suggest that the effects of PAH on the
transport of urate are best explained in the following manner.
When PAH and urate both are present in the luminal perfusion
solution, PAH competes with urate for the putative anion
exchanger in the luminal membrane and thereby inhibits the
absorptive flux of urate. PAH in the lumen enhances the
secretory flux of orate by providing a counter ion for exchange
across the luminal membrane with the urate which entered the
cell across the basolateral membrane. When PAH and urate are
both present in the capillary perfusion solution, each anion
enters the cell by a separate mechanism, but PAH inhibits the
cell to lumen flux of urate by competing with urate for transport
across the luminal membrane. Finally, PAH in the capillary
solution enhances the absorptive flux of urate by entering the
cell and exchanging for urate in the lumen across the brush-
border membrane of the cell.
In the above discussion, we have interpreted the results
obtained with the anion inhibitors and PAH on the transport of
orate under the assumptions that the transport of urate across
the luminal membrane occurs by a process of anion exchange
and that PAH and orate both have affinity for this transporter.
Both of these assumptions derive from in vitro observations in
Table 3. U rate absorptiona
N L CF/PF1,, Ja
Control 18 1.4 0.1 1.00 0.65 —
PAH-urate 14 1.4 + 0.7 0.98 + 0.01 0.30 0.04 <0.02
PAH-capillary 15 1.4 + 0.! 0.98 0.02 1.17 0.15 <0.01
SITS-lumen 16 1.4 0.1 0.98 0.01 0.33 0.08 <0.04
SITS-capillary 16 1.5 0,1 0.99 0.01 0.35 '4 0.07 <0.04
Abbreviations: N, number of observations; L, length in mm; Ja. the
absorptive flux of urate in pmole mm mm '; P. the statistical
significance versus the control observations.
Values represent the mean SEM.
h The initial concentration of orate in the microperfusion solution was
0.4 msi.
isolated membranes [14—181. The present experiments, while
consistent with the in vitro observations, do not offer unambig-
uous proof. It is, in fact, possible to explain the results of the
current studies without postulating that orate and PAH cross
the luminal membrane by an anion exchange mechanism. It is
beyond the scope of this discussion to detail all the alternative
possibilities, but a few examples may be of value to illustrate
these considerations. Suppose, for the sake of this discussion,
that the transport of orate across the luminal membrane occurs
by a non-anion exchange process and that this process is
inhibitable by PAH and perhaps other anions. The apparent
enhancement of urate absorption when PAH is present in the
capillary perfusion solution, then, could be explained by postu-
lating that PAH entered the cell across the basolateral mem-
brane and inhibited the recycling of absorbed urate from the cell
back into the lumen. The enhanced rate of urate secretion when
PAH is present in the lumen could be explained by postulating
that PAH inhibits the back reabsorption of secreted urate rather
than assuming that PAH exchanges with urate in the cell. It is
also possible that the inhibitory effect of SITS, DIDS, and
furosemide on the flux of orate is the consequence of a drug-
induced inhibition of the transport of other anions with specific-
ity for the orate carrier. If such were the case, the effects of
these agents could not be taken as proof that urate itself is
transported by a process of anion exchange. The present
studies, clearly, do not preclude any of the above or other
related possibilities.
Our results also bear on a previously reported discrepancy
between the unidirectional and net fluxes of urate in the
proximal tubule of the rat. In our prior studies, at any given
concentration of urate, the unidirectional flux of urate from the
capillary to the lumen exceeded that from lumen to interstitium
[22, 291. Despite these findings, the net flux of urate, deter-
mined from studies in which the capillary and the lumen were
perfused with artificial solutions containing the same concentra-
tion of radioactive urate, was in the absorptive and not in the
secretory direction [6]. We previously hypothesized that one
possible explanation for the above findings was that rat blood
contained an inhibitor of orate absorption since the absorptive
flux was determined from studies in which only the lumen was
microperfused while the secretory studies and the isotopic net
flux studies were determined utilizing the techniques of simulta-
neous capillary and luminal microperfusion [33]. The present
studies would indicate that our speculation was incorrect. The
absorptive flux of urate, at least at the concentration examined,
Table 2. Urate secretiona
N L CF/PF1,, J, P
Control 24 1.3 0.1
Uratelumenb 19 1.3 0.3
PAH-lumen 18 1.2 ÷ 0.1
PAH-capillary 13 1.3 0.1
SITS-lumen 30 1.4 0.1
SITS-capillary 25 1.2 ÷ 0.1
0.99 0.01 2.72 0.29 —
0.99 it 0.01 3,99 0.56 <0.04
1.00 0.01 3.93 ÷ 0.41 <0.02
1.03 0.02 1.71 0.20 <0.02
1.01 0.02 1.86 0.20 <0.02
0.98 '- 0.01 1.57 0.20 <0.01
Abbreviations: N, number of observations; L, length in mm; J, the
secretory flux of urate in pmole mm mm ; P is the statistical
significance versus the control observations.
a Values represent the means sEM.
The concentration of urate in the capillary perfusion solution was
0.4 mM.
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was similar whether or not the capillary was perfused with
blood or with an artificial electrolyte solution. The present
results also confirm our prior studies and indicate that the
secretory flux exceeds the absorptive flux, the magnitude of
which is similar to that previously reported. A definitive
explanation of this disparity, however, is not currently avail-
able, and additional studies will be required.
Acknowledgments
The authors thank Ms. D. Steplock for technical assistance and Ms.
T. M. Larkin for secretarial assistance.
Reprint requests to Dr. E. J. Weinman, Division of Nephrology,
MSMB 4136, University of Texas Medical School, P.O. Box 20708,
Houston, Texas 77025, USA
References
1. ABRAMSON R, LEVITT MF: Micropuncture study of uric acid
transport in rat kidney. Am J Physiol 228:1597—1605, 1975
2. ROCH-RAMEL F, DEROUGEMONT D, PETERS G, WEINER IM:
Micropuncture study of urate excretion by the kidney of the rat, the
Cebus monkey and the rabbit, in Amino Acid Transport and Uric
Acid Transport, edited by SILBERNAGEL S, LANG F, GREGER A.
Stuttgart, Georg Thieme, 1976, pp. 188—192
3. DEROUGEMONT D, HENCHOZ M, ROCH-RAMEL F: Renal urate
excretion at various plasma concentrations in the rat: A free-flow
micropuncture study. Am J Physiol 231:387—302, 1976
4. SENEKJIAN HO, KNIGHT TF, WEINMAN EJ: Micropuncture of the
renal handling of (6-'4C) urate in the rat. Miner Electrolyte Metabol
2:155—160, 1979
5. FROMMER JP, SHETH AU, SENEKJIAN HO, BABIN0 H, WEINMAN
EJ: Free-flow micropuncture study of renal urate transport in the
Munich-Wistar rat. Miner Electrolyte Metabol 7:324—330, 1982
6. WEINMAN EJ, SENEKJIAN HO, SANSOM SC, STEPLOCK D, SHETH
AU, KNIGHT TF: Evidence for active and passive urate transport in
the rat proximal tubule. Am J Physiol 240:F90—F93, 1981
7. ROCH-RAMEL F, DIEZI-CHOMETY F, DEROUGEMONT D, TELLER
M, WIDMER J, PETERS G: Renalexcretion of uric acid in the rat: A
micropuncture and microperfusion study. Am J Physiol 230:768—
776, 1976
8. WEINMAN EJ, SANSOM SC, STEPLOCK DA, SENEKJIAN HO,
KNIGHT TF: Stopped-flow microperfusion studies of urate absorp-
tion from the rat proximal tubule. Proc Soc Exp Biol Med 164:540—
544, 1980
9. KNIGHT TF, SENEEJIAN HO, SANSOM SC, WEINMAN EJ: The
effects of intraluminal D-glucose and probenecid on urate absorp-
tion in the rat proximal tubule. Am J Physiol 236:F526—F529, 1979
10. WEINMAN EJ, KNIGHT TF, MCKENZIE R, EKNOYAN G: Dissocia-
tion of urate from sodium transport in the rat proximal tubule.
Kidney mt 10:295—300, 1976
11. ARONSON PS, SACKTOR B: The Na+ gradient-dependent transport
of D-glucose in renal brush border membranes. J Biol Chem
250:6032—6039, 1975
12. SACKTOR B: Mechanisms and specificities of amino acid transport
in proximal tubule luminal membrane vesicles, in Renal Function,
edited by GIEBI5H GH, PURRELL EF. New York, Josiah Macy, Jr.
Foundation, 1978, pp. 221—229
13. HOFFMAN N, THEE5 M, KINNE R: Phosphate transport by isolated
renal brush border vesicles. Pfluegers Arch 362: 147—156, 1976
14. BLOMSTEDT JW, AR0N50N PS: pH gradient-stimulated transport of
urate and p-aminohippurate in dog renal microvillus membrane
vesicles. J Clin Invest 65:931—934, 1980
15. KAHN AM, ARONSON PS: Mechanism of urate transport in dog
renal cortical microvillus membrane vesicles (MMV) (abstract).
Kidney hit 19:245, 1981
16. KAHN AM, ARONSON PS: Cl coupled urate transport in dog renal
cortical microvillus membrane vesicles (abstract). Fed Proc 40:463,
1981
17. GUGGINO SE, MARTIN GJ, ARON5ON PS: Coupled pathways for
organic anions in dog renal cortical brush border membrane vesi-
des (abstract). Kidney mt 21:274, 1982
18. KAHN AM, WEINMAN EJ: Hydroxyl-urate and bicarbonate-urate
exchange in rat renal cortical microvillus membrane vesicles (ab-
stract). Kidney mt 21:277, 1982
19. KRAMP RA, LENOIR RH: Characteristics of urate influx in the rat
nephron. Am J Physiol 229:1644—1661, 1975
20. FRANKFURT Si, WEINMAN EJ: Pyrazinoic acid and urate transport
in the rat. Proc Soc Exp Biol Med 159:16—20, 1978
21. FRANKFURT Si, WEINMAN EJ: The effect of probenecid on urate
transport in the rat. Proc Soc Exp Biol Med 155:554—557, 1977
22. WEINMAN EJ, SAN5OM SC, STEPLOCK DA, SHETH AU, KNIGHT
TF, SENEKJIAN HO: The secretion of urate in the proximal convo-
luted tubule of the rat. Am J Physiol 239:F383—F387, 1980
23. PLATTS MM, MUDGE G: Accumulation of uric acid by slices of
kidney cortex. Am J Physiol 200:387—391, 1961
24. ABRAMSON RG, KING VF, REIF MC, LEAL-PINTO E, BARUCH 5:
Urate uptake in membrane vesicles of rat renal cortex: Effect of
copper. Am J Physiol 242:F158—Fl70, 1982
25. KAHN AM, WEINMAN EJ: Urate and PAH transport in basolateral
membrane vesicles from rat kidney (abstract). Kidney mt 23:258,
1983
26. KRAMP RA, LASSITER WE, GOTTSHALK CW: Urate-2-'4C transport
in the rat nephron. J C/in Invest 50:35—48, 1971
27. BOUDRY iF: Effect d'inhibiteurs des transports transtubulaires sur
l'excretion renale d'acide urique chez le rat. Pfluegers Arch
328:279—291, 1971
28. FOULKE5 EC: Peritubular transport of urate in rat kidneys.
Pfluegers Arch 360:1—6, 1975
29. SAN5OM SC, SENEKJIAN HO, KNIGHT TF, BABINO M, STEPLOCK
D, WEINMAN EJ: Determination of the apparent transport con-
stants for urate absorption in the rat proximal tubule. Am J Physiol
240:F406—F410, 1981
30. LUCCI MS, WARNOCK DG: Effects of anion-exchange inhibitors on
NaCI reabsorption in the rat superficial proximal tubule. J Clin
Invest 64:570—579, 1979
31. CABANTCHIK ZI, ROTHSTEIN A: The nature of the membrane sites
controlling anion permeability of human red blood cells as deter-
mined by studies with disulfonic stilbene derivatives. J Membr Biol
10:311—330, 1972
32. BAINES AD, GOTTSCHALK CW, LASSITER WE: Microinjection
study of para-aminohippurate excretion by rat kidneys. Am J
Physiol 214:703—709, 1968
33. WEINER IM, TINKER iP, WEINMAN EJ, SENEKJIAN HO, SANSOM
SC: Kinetic constants for urate transport (letter). Am J Physiol
242:FlOO—F101, 1982
